Clifford Chance
Pot Luck: Marketing cannabis-based products for medicinal use in the UK
27 February 2019
Following several high-profile cases advocating the medicinal benefits of cannabis, in late 2018 the UK government implemented changes to the classification scheduling of cannabis-based products for medicinal use ("CBPMs"). Consequently, it is now possible for businesses to manufacture, import, supply and distribute CBPMs in the UK under certain medical product regulatory regimes.